Diabetes Clinical Trials in San Antonio

Showing 41-60 of 283 trials

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

NCT05761301

To evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-KHK and to evaluate the safety, tolerability, efficacy, PK and PD of multiple doses of KHK.

Type 2 Diabetes Mellitus (T2DM)

Alnylam Pharmaceuticals49 participantsStarted Mar 2023

Phoenix, Arizona, United States • Vista, California, United States • Lake Worth, Florida, United States +12 more locations

COMPLETEDPHASE1< 1 mile

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

NCT04817644

Participants in the study, will receive the study drug once daily for 10 days in tablet form for oral (by mouth) intake. On day 1 to 5 the tablet will contain 3 mg semaglutide, and on day 6-10 the tablet will contain 7 mg semaglutide.

Diabetes Mellitus, Type 2

Novo Nordisk A/S14 participantsStarted Sep 2021

San Antonio, Texas, United States • Salt Lake City, Utah, United States

COMPLETEDPHASE2< 1 mile

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

NCT02010242

NADPH oxidase enzymes (NOX) have been implicated in the development of several diabetic complications including diabetic nephropathy. GKT137831 is the first in class NOX1/4 inhibitor. The primary objective of this study is to evaluate the efficacy of oral GKT137831 in patients with residual albuminuria despite maximal inhibition of the renin angiotensin aldosterone system.

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Calliditas Therapeutics AB136 participantsStarted Oct 2013

Tucson, Arizona, United States • Orange, California, United States • Coral Gables, Florida, United States +45 more locations

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Diabetes Trials in Other Cities

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

VasQ External Support for Arteriovenous Fistula

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

MIRACLE of LIFE Study

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

C-myc Biomarker Study for Diabetic Foot Ulcers

Other Conditions in San Antonio